Replies to post #131 on Arcam AB fka AMAVF

[BiotechValues]

I think XONE's market cap of $840M is where AMAVF will be in 6-12 months as people continue to discover it and they (likely) announce FAST EBM and HiRes EBM intellectual property rights.

This is why:

XONE ttm revenue: $33.8M
AMAVF ttm revenue: $28.0M

XONE revenue/share: $2.55
AMAVF revenue/share: $7.33

XONE ttm EPS (lost .91/share fully diluted)
AMAVF ttm eps + .85/share fully diluted (lowest PE in 3D Printing Stocks)

XONE market cap: $840M
AMAVF market cap: $312M

__________________________________

So I think $150+/share is not unreasonable.

That said, I think they'll have a 2:1 or 3:1 split prior to reaching that level though- liquidity is an issue with the stock with such a tiny float and shares being tightly held.